SKAN Group (SKAN) M&A Announcement summary

Deal rationale and strategic fit

• Acquisition enhances digital transformation and automation capabilities for the life sciences sector, expanding the addressable market and supporting integrated process systems.

• Expands offering to include proprietary MES, Industry 4.0, and digital integration services, strengthening product lifecycle support.

• Metronik's solutions support initiatives like "One Button Release" and paperless pharmaceutical production.

• Strengthens Services & Consumables segment, improving sales, margin profile, and recurring revenue streams.

• Metronik's expertise in energy, environmental, and facility management adds ESG relevance.

Financial terms and conditions

• SKAN will acquire 76% of Metronik, with 24% retained by existing management.

• Financial terms are confidential; purchase is fully financed through bank loans.

• Metronik generated over EUR 25 million in sales in fiscal year 2024.

• Positive contribution to EPS expected in fiscal year 2025.

• Integration of financials will be effective on the date of closing.

Integration plans and timeline

• Metronik will operate as a subsidiary within the Services & Consumables segment.

• Existing management will continue to lead Metronik, which will operate independently post-acquisition.

• Signing of Share Purchase Agreement occurred on 22 May 2025; closing expected in Q3 2025, subject to regulatory approvals.